• Wall Street Doubt Eli Lilly and Company (LLY), Pfizer Inc. (PFE) ALZ Meds More...
• Bristol-Myers Squibb Company (BMY) Hep. C Trial Change Has Big Implications More...
• Alnylam Pharmaceuticals (ALNY) Gets Orphan Status for Neurodegenerative Disease Drug More...
• A.P. Pharma, Inc. (APPA) to Present APF530 Patient-Satisfaction Data from Phase 3 Study More...
• NovaRx Corporation Completes Enrollment in Lucanix Pivitol Phase III Therapeutic Vaccine Trial for Post Frontline Maintenace Therapy in Non Small Cell Lung Cancer More...
• CSL Limited (CMXHF.PK): Viral Component Likely Cause of Convulsions in Kids Given Fluvax More...
• Could Sunlight Lower Your Odds for Pancreatic Cancer? Queensland Institute of Medical Research Study More...
• Arthritis Treatment Linked to Liver Problems, Indiana University Study More...
• First Example of a Heritable Abnormality Affecting Semantic Cognition Found,University College London Study More...
• New Moms Who Blog May Feel Less Alone, Penn State University Study More...
• Babies Don't Get Big and Small Groups, University of Missouri Study More...
• Echo Therapeutics Announces Patents for SymphonyĆ® tCGM System and Prelude® SkinPrep System More...
• AcelRx Pharmaceuticals Receives First U.S. Patent for Small-Volume Oral Transmucosal Dosage Forms More...
• Pfizer Inc. (PFE) Statement Regarding Prevnar 13® Receiving ACIPRecommendation for Prevention of Pneumococcal Disease in Adults With Immunocompromising Conditions More...
• Fast-growing Alexion Pharmaceuticals Inc. (ALXN) to Hire 300 More...
• Tesaro, Inc. Sets Terms for $81 Million US IPO More...
• Cytokinetics, Inc. (CYTK) Nabs $60 Million Financing More...
• Troubled AstraZeneca PLC (AZN) Should Consider Merging With Abbvie: Analysts More...
• AstraZeneca PLC (AZN) Completes Acquisition of Ardea Biosciences, Inc.More...
• Frazier Healthcare Acquires U.S. Commercial Pharmaceutical Packaging Operations from Catalent Pharma Solutions More...
• Drugmakers Including Abbott Laboratories (ABT), Biogen Idec, Inc. (Massachusetts) (BIIB) and Merck & Co., Inc. (MRK) Form Consortium More...
• Cold Spring Harbor Laboratory to Collaborate With Pfizer Inc. (PFE) to Speed Development of New Cancer Therapies More...
• Liquidia Technologies Inc. Announces Product Development Collaboration With GlaxoSmithKline (GSK) More...
• Raptor Pharmaceutical Inc. (RPTP) Licenses Intellectual Property Related to Parkinson's Disease From Universit© Laval More...
• Sistemic Ltd Announces Customer Agreement With Cytori Therapeutics, Inc. (CYTX) More...
• Icahn Nominates Four for Forest Laboratories, Inc. (FRX) Board in Second Fight More...
• Flexion Therapeutics Names Arthur Fratamico Chief Business Officer More...
• ABC Research Corporation Names Lori StephensBusiness Development Director More...
• QUMAS Announces Appointment of Margaret Rice-Jonesas Chairman More...
• China Botanic Pharmaceutical Inc. (Formerly known as Renhuang Pharmaceuticals Inc.) Reports Second Quarter Fiscal Year 2012 Results More...
• Butamax Advanced Biofuels LLC. Comments on Preliminary Injunction Decision and Confirms Intent to Defend Patents More...
• Bristol-Myers Squibb Company (BMY) Hep. C Trial Change Has Big Implications More...
• Alnylam Pharmaceuticals (ALNY) Gets Orphan Status for Neurodegenerative Disease Drug More...
• A.P. Pharma, Inc. (APPA) to Present APF530 Patient-Satisfaction Data from Phase 3 Study More...
• NovaRx Corporation Completes Enrollment in Lucanix Pivitol Phase III Therapeutic Vaccine Trial for Post Frontline Maintenace Therapy in Non Small Cell Lung Cancer More...
• CSL Limited (CMXHF.PK): Viral Component Likely Cause of Convulsions in Kids Given Fluvax More...
• Could Sunlight Lower Your Odds for Pancreatic Cancer? Queensland Institute of Medical Research Study More...
• Arthritis Treatment Linked to Liver Problems, Indiana University Study More...
• First Example of a Heritable Abnormality Affecting Semantic Cognition Found,University College London Study More...
• New Moms Who Blog May Feel Less Alone, Penn State University Study More...
• Babies Don't Get Big and Small Groups, University of Missouri Study More...
• Echo Therapeutics Announces Patents for SymphonyĆ® tCGM System and Prelude® SkinPrep System More...
• AcelRx Pharmaceuticals Receives First U.S. Patent for Small-Volume Oral Transmucosal Dosage Forms More...
• Pfizer Inc. (PFE) Statement Regarding Prevnar 13® Receiving ACIPRecommendation for Prevention of Pneumococcal Disease in Adults With Immunocompromising Conditions More...
• Fast-growing Alexion Pharmaceuticals Inc. (ALXN) to Hire 300 More...
• Tesaro, Inc. Sets Terms for $81 Million US IPO More...
• Cytokinetics, Inc. (CYTK) Nabs $60 Million Financing More...
• Troubled AstraZeneca PLC (AZN) Should Consider Merging With Abbvie: Analysts More...
• AstraZeneca PLC (AZN) Completes Acquisition of Ardea Biosciences, Inc.More...
• Frazier Healthcare Acquires U.S. Commercial Pharmaceutical Packaging Operations from Catalent Pharma Solutions More...
• Drugmakers Including Abbott Laboratories (ABT), Biogen Idec, Inc. (Massachusetts) (BIIB) and Merck & Co., Inc. (MRK) Form Consortium More...
• Cold Spring Harbor Laboratory to Collaborate With Pfizer Inc. (PFE) to Speed Development of New Cancer Therapies More...
• Liquidia Technologies Inc. Announces Product Development Collaboration With GlaxoSmithKline (GSK) More...
• Raptor Pharmaceutical Inc. (RPTP) Licenses Intellectual Property Related to Parkinson's Disease From Universit© Laval More...
• Sistemic Ltd Announces Customer Agreement With Cytori Therapeutics, Inc. (CYTX) More...
• Icahn Nominates Four for Forest Laboratories, Inc. (FRX) Board in Second Fight More...
• Flexion Therapeutics Names Arthur Fratamico Chief Business Officer More...
• ABC Research Corporation Names Lori StephensBusiness Development Director More...
• QUMAS Announces Appointment of Margaret Rice-Jonesas Chairman More...
• China Botanic Pharmaceutical Inc. (Formerly known as Renhuang Pharmaceuticals Inc.) Reports Second Quarter Fiscal Year 2012 Results More...
• Butamax Advanced Biofuels LLC. Comments on Preliminary Injunction Decision and Confirms Intent to Defend Patents More...
0 comments